We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody
Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN
✍ Scribed by Paolo Fabris; Franco Marranconi; Loredana Bozzola; Maria Raffaella Biasin; Franca De Lazzari; Mario Plebani; Paolo Benedetti; Giulia Tositti; Gianpietro Pellizzer; Clara Stecca; Fausto de Lalla
- Book ID
- 106181112
- Publisher
- Springer Japan
- Year
- 1999
- Tongue
- English
- Weight
- 121 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In order to assess the efficacy of interferon‐α on hepatitis C viral RNA in patients with chronic hepatitis C, we analyzed the levels of HCV RNA in sera and liver tissues of 16 patients pre‐ and posttreatment using a semiquantitative polymerase chain reaction method. Fifteen of 16 patie
the changes in serum levels of hepatic fibrogenesis markers We serially measured the levels of serum N-terminal caused by interferon therapy for chronic hepatitis. 9,10 peptide of type III procollagen (PIIINP), the 7S domain In this study, the serum levels of PIIINP, IV-7S, and HA of type IV collag
The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa
We quantified serum hepatitis C virus RNA titers and determined hepatltis C virus subtypes in chronic hepatitis C patients treated with interferon$ to investigate relationships among serum ALT response, serum hepatitis C virus titer and hepatitis C virus subtype. Of 146 chronic hepatitis C patients